Literature DB >> 16045731

Interleukin-10 in murine metal-induced systemic autoimmunity.

B Häggqvist1, P Hultman.   

Abstract

Systemic autoimmune diseases have a complicated and largely unknown aetiology and pathogenesis, but they are at least partly obeying the rules of an ordinary immune response. Cytokines are therefore important in the pathogenesis as demonstrated by the recent success in treating rheumatoid arthritis with anti-cytokine agents. The suppressive functions in the immune system have lately received much interest. One of the cytokines in focus in this respect is interleukin (IL)-10. We recently observed that in heavy-metal induced systemic autoimmunity, genetically resistant mice show a strong increase in IL-10 mRNA expression, which was not seen in susceptible mice. We have therefore examined the possible regulating effect of IL-10 on the induction and manifestation of systemic autoimmunity in this model. We took two approaches: a targeted mutation of the IL-10 gene in a strain resistant to heavy metal-induced autoimmunity, and treatment with recombinant IL-10 in the genetically susceptible A.SW strain during the induction of autoimmunity by metals. The wild-type C57BL/6 J (B6-WT) strain did not react with lymphoproliferation, polyclonal B cell activation, anti-nucleoar autoantibodies (ANoA) or tissue immune-complex (IC) deposits in response to inorganic mercury (Hg) or silver (Ag). However, serum IgG1 and IgE showed a modest increase during Hg treatment, while Ag caused a weak increase in IgE and IgG2a. The B6.129P2-Il10(tm1Cgn)/J strain (IL-10-deficient mice) did not develop antinucleolar antibodies (ANoA) during Hg treatment, but showed a higher median titre of homogeneous ANA compared with Hg-treated B6-WT mice. Both control and Hg-treated (but not Ag-treated) IL-10-deficient mice showed an increase in splenic weight and serum IgG1 compared with B6-WT control and Hg-treated mice. An early, significant increase in serum IgE was seen in Hg-treated IL-10-deficient and WT mice compared with the controls; the increase was 42- and sixfold, respectively. During ongoing intense treatment with rIL-10 in combination with Hg the susceptible A.SW mice showed a reduced development of ANoA and antichromatin antibodies, as well as serum IgE, compared with mice receiving Hg but not rIL-10. In conclusion, IL-10 suppresses several aspects of HgIA, but is not crucial for resistance to heavy metal-induced autoimmunity. Peroral silver treatment suppresses the spontaneous immune activation seen in IL-10-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045731      PMCID: PMC1809456          DOI: 10.1111/j.1365-2249.2005.02878.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3.

Authors:  M Tone; M J Powell; Y Tone; S A Thompson; H Waldmann
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

Review 2.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

Review 3.  Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.

Authors:  P C Taylor; R O Williams; R N Maini
Journal:  Curr Dir Autoimmun       Date:  2000

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.

Authors:  S Cuzzocrea; E Mazzon; L Dugo; I Serraino; D Britti; M De Maio; A P Caputi
Journal:  Eur Cytokine Netw       Date:  2001 Oct-Dec       Impact factor: 2.737

6.  Resistance to xenobiotic-induced autoimmunity maps to chromosome 1.

Authors:  D H Kono; M S Park; A Szydlik; K M Haraldsson; J D Kuan; D L Pearson; P Hultman; K M Pollard
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity.

Authors:  P Hultman; J B Nielsen
Journal:  J Autoimmun       Date:  2001-08       Impact factor: 7.094

8.  Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity.

Authors:  M Abedi-Valugerdi; G Möller
Journal:  Int Immunol       Date:  2000-10       Impact factor: 4.823

9.  Murine metal-induced systemic autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains.

Authors:  B Häggqvist; P Hultman
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

10.  Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes.

Authors:  G Jansson; M Harms-Ringdahl
Journal:  Free Radic Res Commun       Date:  1993
View more
  6 in total

1.  Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study.

Authors:  Renee M Gardner; Jennifer F Nyland; Ines A Silva; Ana Maria Ventura; Jose Maria de Souza; Ellen K Silbergeld
Journal:  Environ Res       Date:  2010-02-21       Impact factor: 6.498

Review 2.  Mercury-induced inflammation and autoimmunity.

Authors:  K Michael Pollard; David M Cauvi; Christopher B Toomey; Per Hultman; Dwight H Kono
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-02-10       Impact factor: 3.770

3.  Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity.

Authors:  Christopher B Toomey; David M Cauvi; Wen-Chao Song; Kenneth M Pollard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

4.  Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways.

Authors:  N Y A Hemdan; I Lehmann; G Wichmann; J Lehmann; F Emmrich; U Sack
Journal:  Clin Exp Immunol       Date:  2007-02-14       Impact factor: 4.330

5.  Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro.

Authors:  Renee M Gardner; Jennifer F Nyland; Sean L Evans; Susie B Wang; Kathleen M Doyle; Ciprian M Crainiceanu; Ellen K Silbergeld
Journal:  Environ Health Perspect       Date:  2009-08-19       Impact factor: 9.031

6.  Cadmium Body Burden and Inflammatory Arthritis: A Pilot Study in Patients from Lower Silesia, Poland.

Authors:  Iwona Markiewicz-Górka; Małgorzata Chowaniec; Helena Martynowicz; Anna Wojakowska; Aleksandra Jaremków; Grzegorz Mazur; Piotr Wiland; Krystyna Pawlas; Rafał Poręba; Paweł Gać
Journal:  Int J Environ Res Public Health       Date:  2022-03-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.